Vergoeding 2016-2020 voor ATC-subgroep J01 : Antibacteriele middelen voor systemisch gebruik
- Raming voor de totale Zvw-populatie
| 2016 | 2017 | 2018 | 2019 | 2020 | |
|---|---|---|---|---|---|
| J01A Tetracyclines | 3.407.400 | 3.159.300 | 2.766.600 | 2.602.000 | 2.439.000 |
| J01B Amfenicolen | . | . | . | 10 | . |
| J01C Betalactam-antibiotica penicillines | 8.314.800 | 8.002.400 | 8.729.500 | 10.303.500 | 11.183.700 |
| J01D Overige betalactam-antibiotica | 4.415.200 | 4.417.100 | 4.706.400 | 5.357.800 | 5.361.200 |
| J01E Sulfonamiden en trimethoprim | 1.018.100 | 1.009.300 | 1.071.000 | 1.324.300 | 1.353.400 |
| J01F Macroliden lincosamiden en streptograminen | 3.769.000 | 3.970.600 | 4.014.700 | 4.748.200 | 4.162.900 |
| J01G Aminoglycosiden | 5.480.100 | 5.001.800 | 4.486.000 | 4.375.100 | 4.091.300 |
| J01M Chinolonen | 1.592.100 | 1.747.500 | 2.150.800 | 2.308.500 | 2.366.600 |
| J01X Overige antibacteriele middelen | 11.012.200 | 10.262.200 | 9.629.100 | 10.220.200 | 10.265.600 |
| Totaal | 39.008.900 | 37.570.200 | 37.554.100 | 41.239.610 | 41.223.700 |